drugset / Trial / NCT02998827

Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD Patients

NCT02998827

Non-randomizedParallel-groupOpen-label

Summary

The effectiveness of thalidomide in treating inflammatory bowel disease has been widely recognized. Meanwhile, many serious adverse drug reactions were notified, but no reports on ovarian reserve function.Therefore, this study was to investigate the influence of thalidomide on function of ovarian reserve.

Timeline

Start
2016-11
Primary completion
2017-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azathioprine Small molecule
Comparator Infliximab Monoclonal antibody
Subject Thalidomide Other / unclassified Oral

Indications